HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Hiscott Selected Research

Carcinoma (Carcinomatosis)

10/2015Crosstalk between the TNF and IGF pathways enhances NF-κB activation and signaling in cancer cells.
8/2005Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Hiscott Research Topics

Disease

41Infections
01/2022 - 04/2002
38Virus Diseases (Viral Diseases)
01/2024 - 03/2002
30Neoplasms (Cancer)
05/2024 - 06/2002
14Vesicular Stomatitis
01/2024 - 10/2004
8Bites and Stings (Sting)
09/2023 - 06/2010
7RNA Virus Infections
06/2023 - 06/2006
6Human Influenza (Influenza)
06/2023 - 08/2005
5COVID-19
01/2022 - 10/2020
5Dengue (Dengue Fever)
01/2020 - 04/2014
4Lymphoma (Lymphomas)
10/2014 - 08/2005
3Prostatic Neoplasms (Prostate Cancer)
01/2019 - 11/2013
3T-Cell Leukemia (Leukemia, T Cell)
12/2014 - 09/2002
3Hodgkin Disease (Hodgkin's Disease)
10/2014 - 02/2003
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2013 - 09/2008
3Melanoma (Melanoma, Malignant)
07/2006 - 09/2002
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2005 - 01/2002
2Pneumonia (Pneumonitis)
01/2022 - 01/2013
2Cytokine Release Syndrome
01/2022 - 09/2015
2Shock
11/2021 - 01/2019
2Adenocarcinoma
12/2020 - 11/2013
2HIV Infections (HIV Infection)
10/2016 - 08/2012
2Carcinoma (Carcinomatosis)
10/2015 - 08/2005
2Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
11/2007 - 01/2002
1Brain Neoplasms (Brain Tumor)
05/2024
1Malaria
11/2021

Drug/Important Bio-Agent (IBA)

41Antiviral Agents (Antivirals)IBA
05/2024 - 06/2002
16Proteins (Proteins, Gene)FDA Link
06/2023 - 06/2002
16Interferon Type IIBA
06/2023 - 06/2002
15InterferonsIBA
01/2022 - 01/2002
10CytokinesIBA
09/2023 - 06/2002
10Transcription Factors (Transcription Factor)IBA
01/2017 - 09/2002
10Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
06/2009 - 06/2002
7DNA (Deoxyribonucleic Acid)IBA
11/2019 - 03/2002
7RNA Helicases (RNA Helicase)IBA
02/2011 - 02/2006
6ChromatinIBA
01/2021 - 08/2005
6Phosphotransferases (Kinase)IBA
01/2020 - 05/2003
6RNA (Ribonucleic Acid)IBA
09/2019 - 06/2009
6NF-kappa B (NF-kB)IBA
01/2014 - 04/2002
5ChemokinesIBA
09/2023 - 06/2002
5Histone Deacetylase InhibitorsIBA
11/2019 - 09/2008
5Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2019 - 07/2006
5Small Interfering RNA (siRNA)IBA
01/2019 - 11/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2015 - 09/2002
5LigandsIBA
10/2015 - 06/2002
5Viral RNAIBA
10/2015 - 08/2009
5Interferon Regulatory FactorsIBA
10/2014 - 04/2002
5I-kappa B KinaseIBA
06/2009 - 10/2004
4VaccinesIBA
01/2022 - 10/2012
4Toll-Like Receptors (Toll-Like Receptor)IBA
11/2021 - 11/2006
4AntioxidantsIBA
11/2020 - 12/2014
4UbiquitinIBA
10/2016 - 10/2006
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 12/2014
3Peptide Hydrolases (Proteases)FDA Link
11/2020 - 12/2007
3cyclic guanosine monophosphate-adenosine monophosphateIBA
11/2019 - 01/2017
3LipopolysaccharidesIBA
10/2011 - 09/2002
3Interferon-betaIBA
07/2007 - 06/2002
3Double-Stranded RNA (RNA, Double Stranded)IBA
07/2006 - 03/2003
3Messenger RNA (mRNA)IBA
02/2006 - 06/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 12/2011
2Neoplasm Antigens (Tumor Antigens)IBA
12/2020 - 12/2011
2Nucleic AcidsIBA
01/2020 - 07/2012
2Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 09/2002
2triphosphoric acid (triphosphate)IBA
09/2019 - 01/2013
2Histone Deacetylases (Histone Deacetylase)IBA
01/2019 - 11/2007
2Trans-Activators (Trans-Acting Factor)IBA
10/2016 - 08/2005
2Ligases (Synthetase)IBA
10/2016 - 10/2006
2Interleukin-6 (Interleukin 6)IBA
10/2015 - 09/2002
2Pattern Recognition ReceptorsIBA
01/2014 - 08/2011
2Pathogen-Associated Molecular Pattern MoleculesIBA
01/2014 - 08/2011
2obatoclaxIBA
07/2013 - 12/2010
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
06/2011 - 02/2006
2Antineoplastic Agents (Antineoplastics)IBA
06/2010 - 09/2008
2Interferon-alpha (Interferon Alfa)IBA
04/2006 - 06/2002
2InterleukinsIBA
08/2005 - 06/2002
2interferon regulatory factor-4IBA
01/2005 - 01/2002
2Phospho-Specific AntibodiesIBA
12/2003 - 03/2003
2Chemokine CCL5IBA
09/2002 - 06/2002
14-octyl itaconateIBA
05/2024
1Cysteine (L-Cysteine)FDA Link
05/2024
1itaconic acidIBA
05/2024
1SARS-CoV-2 spike proteinIBA
01/2024
1Anti-Idiotypic AntibodiesIBA
01/2024
1AntibodiesIBA
01/2024
1Neutralizing AntibodiesIBA
01/2024
1Cisplatin (Platino)FDA LinkGeneric
09/2023
1Conditioned Culture MediaIBA
09/2023
15'PPP-RNAIBA
09/2023
1Neuraminidase (Sialidase)IBA
06/2023
1Protons (Proton)IBA
06/2023
1EndonucleasesIBA
06/2023
1CRISPR-Cas Systems Guide RNAIBA
01/2023
1Glycoproteins (Glycoprotein)IBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1proguanil drug combination atovaquone (malarone)FDA Link
11/2021

Therapy/Procedure

17Therapeutics
01/2023 - 11/2006
6Oncolytic Virotherapy
05/2024 - 06/2010
4Immunotherapy
01/2021 - 01/2017
2Highly Active Antiretroviral Therapy (HAART)
11/2021 - 01/2019
2Investigational Therapies (Experimental Therapy)
01/2021 - 12/2011
1Chemoprevention
11/2021